Our genes in their hands : OPINION

The privatisation to end all privatisations is under way. Multinational drugs corporations and tiny start-up biotechnology companies are busily staking their claim to own human genes. In laboratories around the world, human DNA - the chemical messenger of heredity - is being analysed in minute detail. The compendium of the 100,000 or so human genes is known as the genome, and the goal of lab workers around the world, participating in the international Human Genome Project, is to work out what each gene does.

The benefits will be greater understanding of heredity and human development. Health will also benefit, for many diseases, from diabetes to cancer, have a genetic component.

That means there is money to be made from human genes. Any pharmaceutical company that can corner the market in, say, cancer-causing genes - by patenting them - will enjoy assured profits for years to come. Tomorrow, the House of Commons Select Committeeon Science and Technology will take evidence on the patenting of human genes, as part of its parliamentary investigation into the "new" science of human genetics.

Two years ago the Nuffield Council on Bioethics published a report calling for government regulation of genetic testing and screening. Nothing has been done. The council also called for the insurance industry not to pry into the results of people's genetic tests. Last month, the Association of British Insurers (ABI) told the Select Committee it wants to see all results.

The committee gave the association a bipartisan hard time. A Conservative MP, Spencer Batiste, said it might improve public health if the population were screened, so that individuals would know their risk of developing disease or of having children who might suffer inherited conditions. But people would be discouraged from participating in such screening programmes if they knew the results, recorded on their medical records, would affect their chances of getting life or other insurance cover.

Professor Peter Harper, of University College Cardiff, told the committee he already knew of people who had been tested to see if they carried the gene for Huntington's Chorea (an inherited degenerative brain disease) and who did not want the results transmitted to their GPs because it might prejudice their chances of getting insurance. In Professor Harper's view, the industry was mistaken in regarding the results of genetic tests as part of someone's medical record. If someone who is currently healthy had a genetic test indicating the potential of disease in the future, that information did not alter the fact that the person was healthy now and so should not be entered on his or her medical record.

But Roger Bowley said the ABI opposed legislation that would stop insurers gaining access to the results of genetic tests, even though the committee pointed out no insurance company would be at a disadvantage against its rivals if the law denied access to the information to all companies.

Representatives of families affected by genetic disease are also concerned about genetic discrimination by the insurance industry. Alastair Kent, director of the Genetic Interest Group (GIG), called for proper regulation of the new genetics. But, he warned, it had to be open and transparent and consult interested parties, not be just a committee of the great and good sitting in secrecy.

Mr Kent opposed the trend towards the patenting of human genes: on ethical grounds, as it is intrinsically wrong for a third person to have a patent on something that is part of a person. But GIG is also against patenting on practical grounds. Someone with a headache, Mr Kent pointed out, can buy aspirin, and the existence of a market for headache remedies might stimulate innovation leading to the invention of paracetamol. But if a gene is patented, there is no way an inventor can go beyond the gene itself. A patent on a gene is on product and outcome: "If you own the gene, you have a unique monopoly," he said.

The committee has yet to hear the full evidence. One of the world's biggest pharmaceutical companies, Merck Sharp and Dohme, says it will publish the details of the gene sequences its researchers isolate, thus preventing anyone from claiming patent rights.

SmithKline Beecham, however, has gone into partnership with gene-hunting biotechnology companies, and specifically intends to patent as much as it can. The British company Zeneca believes that "genes are not different from any other area of technology",according to Peter Kolker, the company's intellectual property manager.

"There would not be a pharmaceutical industry if it were not for patents," Mr Kolker continued. "The treatments that are going to come out of gene technology will be beneficial. To deny patenting of sequences would deny that benefit to mankind."

Start your day with The Independent, sign up for daily news emails
Life and Style
love + sex A new study has revealed the average size - but does that leave men outside the 'normal' range being thought of as 'abnormal'?
Arts and Entertainment
The Palace of Westminster is falling down, according to John Bercow
voices..says Matthew Norman
Steve Bruce and Gus Poyet clash
Arts and Entertainment
Jake and Dinos Chapman were motivated by revenge to make 'Bring me the Head of Franco Toselli! '
arts + ents Shapero Modern Gallery to show explicit Chapman Brothers film
Arts and Entertainment
Kurt Cobain performing for 'MTV Unplugged' in New York, shortly before his death
music Brett Morgen's 'Cobain: Montage of Heck' debunks many of the myths surrounding the enigmatic singer
Life and Style
ebooksA special investigation by Andy McSmith
Brendan Rodgers
football The Liverpool manager will be the first option after Pep Guardiola
Arts and Entertainment
Myanna Buring, Julian Rhind-Tutt and Russell Tovey in 'Banished'
TV Jimmy McGovern tackles 18th-century crime and punishment
Arts and Entertainment
Paul Whitehouse as Herbert
arts + ents
Christian Benteke of Aston Villa celebrates scoring the winner for Aston Villa
Bill O'Reilly attends The Hollywood Reporter 35 Most Powerful People In Media Celebration at The Four Seasons Restaurant on April 16, 2014 in New York City
media It is the second time he and the channel have clarified statements
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Lettings and Sales Negotiator - OTE £46,000

£16000 - £46000 per annum: Recruitment Genius: This is an opportunity to join ...

Recruitment Genius: Home Care Worker - Reading and Surrounding Areas

£9 - £13 per hour: Recruitment Genius: This is a great opportunity to join a s...

Recruitment Genius: Key Sales Account Manager - OTE £35,000

£25000 - £35000 per annum: Recruitment Genius: Have you got a proven track rec...

Recruitment Genius: Sales Executive - OTE £40,000

£15000 - £18000 per annum: Recruitment Genius: This is a great opportunity for...

Day In a Page

Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

Climate change key in Syrian conflict

And it will trigger more war in future
How I outwitted the Gestapo

How I outwitted the Gestapo

My life as a Jew in wartime Berlin
The nation's favourite animal revealed

The nation's favourite animal revealed

Women like cuddly creatures whilst men like creepy-crawlies
Is this the way to get young people to vote?

Getting young people to vote

From #VOTESELFISH to Bite the Ballot
Poldark star Heida Reed: 'I don't think a single bodice gets ripped'

Poldark star Heida Reed

'I don't think a single bodice gets ripped'
The difference between America and Israel? There isn’t one

The difference between America and Israel? There isn’t one

Netanyahu knows he can get away with anything in America, says Robert Fisk
Families clubbing together to build their own affordable accommodation

Do It Yourself approach to securing a new house

Community land trusts marking a new trend for taking the initiative away from developers
Head of WWF UK: We didn’t send Cameron to the Arctic to see green ideas freeze

David Nussbaum: We didn’t send Cameron to the Arctic to see green ideas freeze

The head of WWF UK remains sanguine despite the Government’s failure to live up to its pledges on the environment
Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

Set in a mythologised 5th-century Britain, ‘The Buried Giant’ is a strange beast
With money, corruption and drugs, this monk fears Buddhism in Thailand is a ‘poisoned fruit’

Money, corruption and drugs

The monk who fears Buddhism in Thailand is a ‘poisoned fruit’
America's first slavery museum established at Django Unchained plantation - 150 years after slavery outlawed

150 years after it was outlawed...

... America's first slavery museum is established in Louisiana
Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

The first 'American Idol' winner on how she manages to remain her own woman – Jane Austen fascination and all
Tony Oursler on exploring our uneasy relationship with technology with his new show

You won't believe your eyes

Tony Oursler's new show explores our uneasy relationship with technology. He's one of a growing number of artists with that preoccupation
Ian Herbert: Peter Moores must go. He should never have been brought back to fail again

Moores must go. He should never have been brought back to fail again

The England coach leaves players to find solutions - which makes you wonder where he adds value, says Ian Herbert
War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

The battle for Mosul will unleash 'a million refugees'

Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn